Description of long-term polypharmacy among schizophrenia outpatients

被引:0
|
作者
Jaana T. Suokas
Jaana M. Suvisaari
Jari Haukka
Pasi Korhonen
Jari Tiihonen
机构
[1] National Institute for Health and Welfare,Department of Mental Health and Alcohol Research
[2] Helsinki University Central Hospital,Department of Psychiatry
[3] EPID Research Oy,School of Health Sciences
[4] University of Tampere,Department of Clinical Neuroscience/Psychiatry
[5] StatFinn Oy,Department of Forensic Psychiatry, Niuvanniemi Hospital
[6] Karolinska Institutet,Department of Clinical Physiology
[7] University of Eastern Finland,Department of Mental Health and Substance Abuse Services
[8] Kuopio University Hospital,undefined
[9] National Institute for Health and Welfare,undefined
关键词
Schizophrenia; Antipsychotics; Polypharmacy; Long-term; Outpatient treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:631 / 638
页数:7
相关论文
共 50 条
  • [31] Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria
    Igbinomwanhia, Nosa Godwin
    Olotu, Sunday Osasu
    James, Bawo Onesirosan
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (01) : 3 - 10
  • [32] LONG-TERM TREATMENT OF OUTPATIENTS WITH DEPOT NEUROLEPTICS
    SAAMELI, W
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1981, 70 (06): : 206 - 210
  • [33] A retrospective survey of outpatients with long-term tracheostomy
    Björling, G
    Johansson, UB
    Andersson, G
    Schedin, U
    Markström, A
    Frostell, C
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2006, 50 (04) : 399 - 406
  • [34] An epidemiological and long-term outcome perceptive on antipsychotic polypharmacy
    Waddington, J. L.
    Browne, D. J.
    Scuily, P. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S201 - S201
  • [35] MONITORING AND REDUCING POLYPHARMACY IN THE LONG-TERM CARE FACILITY
    SHAH, IC
    GOLD, L
    KALT, E
    BRYAN, WP
    WAGNER, AH
    PYLE, P
    URBACH, AL
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (08) : A33 - A33
  • [36] LONG-TERM MEDICATION USE AND POLYPHARMACY IN OLDER ADULTS
    Egici, Memet Taskin
    Bagci, Hasan
    Gurel, Nermin
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2021, 24 (02): : 122 - 133
  • [37] Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
    Ascher-Svanum, Haya
    Novick, Diego
    Maria Haro, Josep
    Bertsch, Jordan
    McDonnell, David
    Detke, Holland
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1125 - 1131
  • [38] Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina
    Markovic-Pekovic, Vanda
    Skrbic, Ranko
    VOJNOSANITETSKI PREGLED, 2016, 73 (05) : 435 - 441
  • [39] LONG-TERM FUNCTIONAL IMPROVEMENTS IN THE 2-YEAR TREATMENT OF SCHIZOPHRENIA OUTPATIENTS WITH OLANZAPINE LONG-ACTING INJECTION
    Ascher-Svanum, Haya
    Novick, Diego
    Haro, Josep M.
    Bertsch, Jordan
    McDonnell, David
    Detke, Holland
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S165 - S165
  • [40] Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
    Samuel S. Allemann
    Kenneth M. Dürsteler
    Johannes Strasser
    Marc Vogel
    Marcel Stoeckle
    Kurt E. Hersberger
    Isabelle Arnet
    Harm Reduction Journal, 14